Invention Grant
- Patent Title: Bromodomain inhibitors
-
Application No.: US14392201Application Date: 2014-06-27
-
Publication No.: US09957263B2Publication Date: 2018-05-01
- Inventor: Yujia Dai , Steven D. Fidanze , Lisa Hasvold , James Holms , Dachun Liu , William McClellan , Keith McDaniel , Jasmina Marjanovic , George Sheppard , Le Wang
- Applicant: AbbVie Inc.
- Applicant Address: US IL North Chicago
- Assignee: AbbVie Inc.
- Current Assignee: AbbVie Inc.
- Current Assignee Address: US IL North Chicago
- Agent Michael S. Montgomery
- International Application: PCT/CN2014/080991 WO 20140627
- International Announcement: WO2014/206345 WO 20141231
- Main IPC: C07D471/02
- IPC: C07D471/02 ; A61K31/44 ; A61K31/497 ; C07D471/04 ; A61K45/06 ; A61K31/437 ; A61K31/496 ; A61K31/5377 ; A61K31/541 ; A61K31/551 ; A61K31/4545 ; A61K31/506
Abstract:
Compounds of formula (I) and pharmaceutically acceptable salts thereof are provided. The compounds are useful as agents in the treatment of diseases and conditions, including inflammatory diseases, cancer, and AIDS. Pharmaceutical compositions comprised of one or more compounds of formula (I) are also provided.
Public/Granted literature
- US20160272630A1 Bromodomain Inhibitors Public/Granted day:2016-09-22
Information query
